Drug Target Exploitable Structural Features of Adenylyl Cyclase Activity in Schistosoma mansoni

Area of Science:

• Parasitology
• Structural Bioinformatics
• Molecular Biology

Background:

• Schistosomiasis is a debilitating disease caused by the parasitic flatworm Schistosoma mansoni.
• The parasite's genome encodes Smp_059340.1, a guanosine triphosphate (GTP) binding protein.
• Smp_059340.1 is a potential drug target due to its role in regulating adenylyl cyclase activity.

Purpose of the Study:

• To elucidate the structural and functional characteristics of the Smp_059340.1 protein.
• To identify key amino acid residues involved in the protein's GTP/GDP binding and cycling.
• To provide insights for developing targeted therapies against Schistosoma mansoni.

Main Methods:

• Draft genome sequence analysis of Schistosoma mansoni.
• Structural bioinformatics to identify key amino acid residues.
• Analysis of molecular switches and binding interfaces.

Main Results:

• Identified critical residues (Ser53, Thr188, Asp207, Gly210) in Smp_059340.1's molecular switches.
• Characterized the roles of Thr188 (Switch I) and Gly210 (Switch II) in protein activation.
• Located Asp207 within the G3 box motif and Ser53 as the magnesium ion binding residue.

Conclusions:

• The identified residues and binding interfaces are crucial for Smp_059340.1 function in the parasite's life cycle.
• These findings offer potential starting points for small molecule or peptide-based drug development.
• Targeting Smp_059340.1 could lead to novel therapeutic strategies against schistosomiasis.